Bibliographic Details
| Title: |
Non-coding RNA in drug resistance of hepatocellular carcinoma. |
| Authors: |
Bisha Ding1,2,3 (AUTHOR), Weiyang Lou1,2,3 (AUTHOR), Liang Xu1,2,3 (AUTHOR), Weimin Fan1,2,3 (AUTHOR) fanw@zju.edu.cn |
| Source: |
Bioscience Reports. 10/31/2018, Vol. 38 Issue 5, p1-10. 10p. 1 Diagram, 3 Charts. |
| Abstract: |
Hepatocellular carcinoma (HCC) has been one of the most highly lethal cancers. The acquisition of drug resistance accounts for the majority of poor effects of chemotherapy in HCC. Non-coding RNAs (ncRNAs) including miRNAs, long ncRNAs (lncRNAs), and circular RNA (circRNA) have been well-documented to participate in cancer occurrence and progression. Recently, multiple studies have highlighted the key roles of ncRNAs in chemoresistance of HCC. In addition, accumulating evidence has demonstrated that they can serve as biomarkers in diagnosis, treatment, and prognosis of HCC. In this review, we first overviewed up-to-date findings regarding miRNA and lncRNA in drug resistance of HCC, then summarized specific mechanisms that they modulate chemoresistance of HCC, and finally discussed their potential clinical application in overcoming the obstacle of HCC chemoresistance in the future. [ABSTRACT FROM AUTHOR] |
|
Copyright of Bioscience Reports is the property of Portland Press Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
